quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:30·4d
SECFiling
Longeveron Inc. logo

SEC Form EFFECT filed by Longeveron Inc.

LGVN· Longeveron Inc.
Health Care
Original source

Companies

  • LGVN
    Longeveron Inc.
    Health Care

Recent analyst ratings

  • Dec 6UpdateROTH MKM$10.00
  • Jan 5UpdateEF Hutton$20.00

Related

  • PR19h
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC6d
    SEC Form 424B3 filed by Longeveron Inc.
  • SEC13d
    Longeveron Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • SEC13d
    SEC Form S-1 filed by Longeveron Inc.
  • PR13d
    Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
  • PR15d
    Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
  • INSIDER20d
    SEC Form 4 filed by Lehr Paul T
  • INSIDER20d
    SEC Form 4 filed by Locklear Lisa
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022